logo-loader

Futura Medical announce regulatory and commercial progress on erectile disfunction gel

Published: 14:03 22 Oct 2020 BST

Futura Medical PLC's (LON:FUM) James Barder talks to Proactive London's Katie Pilbeam about the announcement made today on the regulatory progress in the US.

Barder also hints upon significant commercial interest for its erectile dysfunction gel with talks ongoing with a growing number of potential partners.

Med3000 is an over-the-counter treatment and as a consequence would have huge commercial potential. Barder is confident the negotiations with the FDA will be satisfactorily and is planning for a Q1 confirmation.

Futura Medical marks pivotal year with first meaningful revenue from Eroxon...

Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder tells Proactive's Stephen Gunnion that 2023 was a pivotal year for the company as it rolled out its innovative sexual health product, Eroxon, designed to treat erectile dysfunction. The over-the-counter availability of Eroxon distinguishes...

on 7/2/24